2318.4000 -1.60 (-0.07%)
NSE Aug 14, 2026 15:31 PM
Volume: 629.1K
 

2318.40
-0.07%
Geojit BNP Paribas
*over or under performance to benchmark index Glenmark Pharmaceuticals Ltd, which has a presence in over 80 countries, focuses on the generics, specialty and over-the-counter (OTC) segments, with a strong presence in diabetes, cardiovascular and oral contraceptives. In Q4FY26, Glenmark's normalized revenue grew 11.1% YoY to Rs. 3,616cr, driven...
Deven Choksey increased Accumulate price target of Glenmark Pharmaceuticals Ltd. to 2563.0 on 07 Aug, 2026.
More from Glenmark Pharmaceuticals Ltd.
Recommended